CML is a rare cancer of the white blood cells. It is a form of leukemia characterized by the increased and unregulated growth of myeloid cells in the bone marrow and the accumulation of these cells in the blood. With the average age of diagnosis of CML being around 60 in western countries, CML in children is considered an ultra-rare condition. Read more about paediatric CML here.
Please see the list of publications on pediatric CML here. A number of clinical trials and research activities are currently ongoing to research pediatric CML. Find more information about ongoing research here.
Our online discussion forum "Difficult CML Cases" features a number of discussions on pediatric CML cases. If you are a physician treating pediatric CML patients, please join our forum and get in touch with other experts.
This section is developed in close partnership with the CML Advocates Network. There are a number of patient groups supporting pediatric CML patients and their family members. Find more information about this here.
The "CML Advocates Network", the international platform of patient groups supporting patients and relatives suffering from Chronic Myeloid Leukaemia, and the International CML Foundation join forces to support young patients affected by that rare form of leukaemia, as well as physicians and researchers. The project, launched on International Childhood Cancer Day on 15 February 2011, will encompass a range of activities to support collaboration and sharing of experience of parents of young patients as well as physicians treating children with this ultra-rare condition.